Conversely, impaired PPARγ signalling or dysregulated VLCFA metabolism may contribute to ectopic lipid accumulation, chronic inflammation and the development of obesity‐related metabolic disorders such as obesity and type 2 diabetes [49]. This evidence concerns the gene PPARG and metabolic disease.